Cargando…

Ex Vivo Expanded Human NK Cells Survive and Proliferate in Humanized Mice with Autologous Human Immune Cells

Adoptive immune cell therapy is emerging as a promising immunotherapy for cancer. Particularly, the adoptive transfer of NK cells has garnered attention due to their natural cytotoxicity against tumor cells and safety upon adoptive transfer to patients. Although strategies exist to efficiently gener...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vahedi, Fatemeh, Nham, Tina, Poznanski, Sophie M., Chew, Marianne V., Shenouda, Mira M., Lee, Dean, Ashkar, Ali A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608690/ https://www.ncbi.nlm.nih.gov/pubmed/28935883 http://dx.doi.org/10.1038/s41598-017-12223-8

Ejemplares similares

Expanded human NK cells armed with CAR uncouple potent anti-tumor activity from off-tumor toxicity against solid tumors
por: Portillo, Ana L., et al.
Publicado: (2021)

Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours
por: Shenouda, Mira M., et al.
Publicado: (2017)

Reconstitution of immune cell in liver and lymph node of adult- and newborn-engrafted humanized mice
por: Dykstra, Crystal, et al.
Publicado: (2016)

Expanded human NK cells from lung cancer patients sensitize patients’ PDL1−negative tumors to PD1-blockade therapy
por: Poznanski, Sophie M, et al.
Publicado: (2021)

What Defines NK Cell Functional Fate: Phenotype or Metabolism?
por: Poznanski, Sophie M., et al.
Publicado: (2019)

Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection
por: Lee, Amanda J., et al.
Publicado: (2017)

Type I Interferon Receptor on NK Cells Negatively Regulates Interferon-γ Production
por: Lee, Amanda J., et al.
Publicado: (2019)

Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due
por: Shapiro, Roman M., et al.
Publicado: (2022)

Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
por: Voskens, Caroline J, et al.
Publicado: (2010)

Autologous NK cells propagated and activated ex vivo decrease senescence markers in human PBMCs
por: Chelyapov, Nickolas, et al.
Publicado: (2022)

IFN-β signalling regulates RAW 264.7 macrophage activation, cytokine production, and killing activity
por: Karimi, Yalda, et al.
Publicado: (2019)

Phase I Clinical Trial Using Autologous Ex Vivo Expanded NK Cells and Cytotoxic T Lymphocytes for Cancer Treatment in Vietnam
por: Liem, Nguyen Thanh, et al.
Publicado: (2019)

Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro
por: Portillo, Ana L., et al.
Publicado: (2021)

Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment
por: Orrantia, Ane, et al.
Publicado: (2021)

Frequency of Human CD45+ Target Cells is a Key Determinant of Intravaginal HIV-1 Infection in Humanized Mice
por: Nguyen, Philip V., et al.
Publicado: (2017)

Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model
por: Gillgrass, Amy E, et al.
Publicado: (2015)

Susceptibility of Human Melanoma Cells to Autologous Natural Killer (NK) Cell Killing: HLA-Related Effector Mechanisms and Role of Unlicensed NK Cells
por: Carrega, Paolo, et al.
Publicado: (2009)

Evaluation of allogeneic and autologous membrane-bound IL-21–expanded NK cells for chronic lymphocytic leukemia therapy
por: Yano, Max, et al.
Publicado: (2022)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

In vivo Prevention of Transplant Arteriosclerosis by ex vivo Expanded Human Regulatory T Cells
por: Nadig, Satish N., et al.
Publicado: (2010)

Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge
por: Kwant-Mitchell, Amanda, et al.
Publicado: (2009)

NK Cells in the Human Lungs
por: Hervier, Baptiste, et al.
Publicado: (2019)

Identification of Human NK17/NK1 Cells
por: Pandya, Abhilash D., et al.
Publicado: (2011)

Ex Vivo Expansion of Human CD8(+) T Cells Using Autologous CD4(+) T Cell Help
por: Butler, Marcus O., et al.
Publicado: (2012)

Ex-vivo expanded human NK cells mediate cytotoxicity and cytokine release against allogeneic cancer cell line by direct recognition and antibody directed cellular cytotoxicity: therapeutic potential use of NK cells for blood and solid tumors
por: Liacini, Abdelhamid, et al.
Publicado: (2014)

Genital HSV-2 Infection Induces Short-Term NK Cell Memory
por: Abdul-Careem, Mohamed F., et al.
Publicado: (2012)

Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer
por: Koh, Eun-Kyoung, et al.
Publicado: (2023)

Transplantation of Autologous Ex Vivo Expanded Human Conjunctival Epithelial Cells for Treatment of Pterygia: A Prospective Open-label Single Arm Multicentric Clinical Trial
por: Vasania, Viraf Sam, et al.
Publicado: (2014)

Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1
por: Kruse, Vanessa, et al.
Publicado: (2015)

LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity
por: Leijonhufvud, Caroline, et al.
Publicado: (2021)

Ex Vivo Expanded Human Regulatory T Cells Can Prolong Survival of a Human Islet Allograft in a Humanized Mouse Model
por: Wu, Douglas C., et al.
Publicado: (2013)

UM171 expands distinct types of myeloid and NK progenitors from human pluripotent stem cells
por: Mesquitta, Walatta-Tseyon, et al.
Publicado: (2019)

The HOXB4 Homeoprotein Promotes the Ex Vivo Enrichment of Functional Human Embryonic Stem Cell-Derived NK Cells
por: Larbi, Aniya, et al.
Publicado: (2012)

P16. Differential susceptibility of human and mouse NK cells to malignant cell-induced abnormalities in autologous combinations: a potential mechanism for the NK cell-based immunotherapy efficacy
por: Sconocchia, G, et al.
Publicado: (2014)

Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
por: Koh, Eun-Kyoung, et al.
Publicado: (2023)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans
por: Naujoks, Wiebke, et al.
Publicado: (2020)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality
por: Persyn, Eva, et al.
Publicado: (2022)

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
por: Slattery, Karen, et al.
Publicado: (2021)

“Adherent” versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy
por: Selvan, Senthamil R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_buih7lg5nubvk610dkpfr7ikgd